The prognostic value of Krebs von den Lungen-6 and surfactant protein-A levels in the patients with interstitial lung disease
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Translational Internal Medicine
- Vol. 9 (3) , 212-222
Abstract
Background and Objectives: The highly variable clinical course of interstitial lung disease (ILD) makes it difficult to predict patient prognosis. Serum surfactant protein-A (SP-A) and Krebs von den Lungen-6 (KL-6) are known prognostic biomarkers. However, the clinical or pathophysiological differences in patients with these biomarkers have not been well evaluated. We investigated the clinical and pathophysiological differences through the comparison of SP-A and KL-6 levels before and after treatment. Methods: This study included retrospective data from 91 patients who were treated for ILD between August 2015 and September 2019. Serum SP-A and KL-6 levels were measured before and after treatment. The patients were followed up for 3 months. Results: Changes in the serum biomarkers (Delta SP-A and Delta KL-6) were found to be significantly correlated (rs = 0.523, P < 0.001); Delta SP-A and Delta KL-6 were inversely correlated with changes in pulmonary function (% predicted values of diffusing capacity for carbon monoxide [DLCO], forced vital capacity [FVC], and forced expiratory volume in 1 s [FEV1]). Patients were divided into four groups based on their Delta SP-A and Delta KL-6 levels in a cluster analysis (G1, G2, G3, and G4). Both SP-A and KL-6 were elevated in the G1 group, with all the patients enrolled classified as progressive or unchanged, and 86.4% of patients showed improved disease activity in the G4 group, where both SP-A and KL-6 levels were reduced. In the G2 group, only SP-A levels decreased post-treatment, indicating an improvement in respiratory function; the patients were not at the end stage of the disease. Only the SP-A levels increased in the G3 group with immunosuppressive treatment. Conclusions: Reduced serum SP-A and/or KL-6 levels are associated with improved lung function in patients with ILD. Some patients only showed a decrease in SP-A levels could prognosis an improvement in respiratory function. When only SP-A is increased, it may imply that the patients are at an early stage of disease progression. As a result, for proper disease monitoring, measuring both markers is important.Keywords
This publication has 40 references indexed in Scilit:
- Serum heat shock protein 47 levels in patients with drug-induced lung diseaseRespiratory Research, 2013
- The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-DBMC Pulmonary Medicine, 2012
- Biomarkers in idiopathic pulmonary fibrosisCurrent Opinion in Pulmonary Medicine, 2012
- Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumoniasDiagnostic Pathology, 2011
- Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with SclerodermaThe Journal of Rheumatology, 2009
- Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ratio with histological patternsThorax, 2008
- Gefitinib‐induced interstitial lung disease showing improvement after cessation: Disassociation of serum markersRespirology, 2006
- High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumoniaThorax, 2003
- Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease ExtentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- New Serum Indicator of Interstitial Pneumonitis ActivityChest, 1989